Browsing Tag
oncology strategy
2 posts
AKEEGA moves upstream as CHMP backs PARP inhibition in metastatic hormone-sensitive prostate cancer
Find out how CHMP support for AKEEGA could shift PARP inhibitors into earlier prostate cancer treatment and reshape precision oncology strategy.
February 9, 2026
Can asciminib reshape first-line CML treatment? Inside Scemblix’s rise as a new standard of care in Canada
More than a month after Health Canada’s approval, Scemblix is forcing a rethink of chronic myeloid leukemia therapy—and raising the bar for tolerability and precision.
August 31, 2025